We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enhanced Immunochemistry Analyzers Offer Workstation Consolidation and Efficiency

By LabMedica International staff writers
Posted on 09 Sep 2010
Print article
A family of immunochemistry analyzers offers enhanced automation, workstation consolidation, high efficiency, and labor savings for laboratories of all sizes.

The features of the new immunochemistry analyzers, dubbed Architectplus, include more comprehensive and user-friendly software; a smaller size to help reduce space requirements; improvements to streamline operations and reduce interruptions; new video instructions to help with routine maintenance; and an attractive exterior design and styling.

A product of Abbott (Abbott Park, IL, USA), existing Architect systems can be upgraded to Architectplus onsite. The analyzers have an extensive menu of more than 170 assays. Laboratories will be able to reduce labor, optimize throughput, and enhance overall productivity, while standardizing data management processes and optimizing inventory control. The new features will minimize training, and reduce inventory costs and sample contamination potential, resulting in improved performance and outcomes for laboratories, physicians, and patients.

Two new assays recently added were the HE4 for early detection and monitoring of ovarian cancer and the human immunodeficiency virus (HIV) antigen/antibody Combo Assay to identify early HIV infections. Additionally, Abbott has more than a dozen novel biomarkers in development, and several are expected to be introduced within months of the introduction of the analyzers.


"According to the Health and Human Services Administration on Aging, one in five Americans will be age 65 and older in 20 years. It's well documented that older people are the largest consumers of health care services, and the huge growth in this age group will likely generate significant new demand for routine lab tests and follow-up testing for diabetes, cancer and other conditions," said Brian Blaser, senior vice president, diagnostics, Abbott. "Already stressed with finding ways to deal with diminishing resources and a serious shortage of trained staff, laboratories are turning to diagnostics manufacturers for technologies and capabilities they need to operate effectively and survive in this environment."

Architectplus was showcased for the first time at the annual American Association for Clinical Chemistry Lab Expo, which was held in Anaheim, (CA, USA) from July 25-29, 2010.

Related Links:

Abbott
American Association for Clinical Chemistry



New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chemistry Analyzer
MS100
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.